Amphastar Pharmaceuticals, Inc. AMPH
NASDAQ · United States · Health Technology
$25.67-0.14 (-0.56%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | 0.91 | 0.62 | +46.8% | $183.90M | +2.2% | +2.7%$20.24→$20.78 |
| Q1 2026 | 2026-05-07 | 0.26 | 0.62 | -58.1% | — | — | -20.5%$23.90→$19.00 |
| Q4 2025 | 2026-02-26 | 0.61 | 0.89 | -31.5% | — | — | -27.7%$27.97→$20.23 |
| Q3 2025 | 2025-11-06 | 0.83 | 0.73 | +13.7% | — | — | -5.1%$25.31→$24.03 |
| Q4 2023 | 2024-02-28 | 0.88 | 0.91 | -3.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.